v3.26.1
Unaudited Condensed Consolidated Interim Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 1 $ 57
Other receivables
Total Current Assets 272 841
Investment in unconsolidated entity 121
Total assets 272 962
Current Liabilities    
Trade payable 1,435 1,545
Other accounts liabilities 1,388 1,246
Liabilities to an unconsolidated entity 60 175
Warrants liability, net 212 127
Notes and Loan payable 1,476 1,817
Total Current Liabilities 4,571 4,910
Long Term Liabilities    
Investment in unconsolidated entity 12
Total Liabilities 4,583 4,910
Stockholders’ Deficit    
Common stock, 0.001 par value each: 27,692,308 shares authorized as of June 30, 2026 and December 31, 2025, respectively; issued and outstanding 7,942,407 shares as of June 30, 2026 and 4,377,388 as of December 31, 2025. 8 4
Additional paid-in capital 56,925 55,836
Treasury Stock (33) (33)
Receipts on account of shares 71
Accumulated deficit (61,211) (59,826)
Total Stockholders’ Deficit (4,311) (3,948)
Total Liabilities and Stockholders’ Deficit 272 962
Related Party    
Current Assets    
Accounts Receivables – related parties 271 271
Other receivables – related parties $ 513